AcneFree Purchase Builds U.S. Scale For Canadian Dermatology Firm

The addition of AcneFree to Valeant Pharma’s OTC portfolio will complement the Montreal firm’s CeraVe skin hydration line and augment its shelf space in U.S. retail doors. Valeant announced $64 million purchase from University Medical earlier this month.

More from Archive

More from HBW Insight